When labs are ordered in GLP-1 treatment, providers typically look at markers that help evaluate metabolic function, organ health, and potential risk factors: A1C and fasting glucose: to assess baseline glycemic control [2] Kidney function: to monitor dehydration risk and fluid balance, which GLP-1-related gastrointestinal side effects can affect [3] Liver enzymes: to ensure safe medication clearance and dosing [4] Lipid panel: to track key cardiometabolic markers that often shift with weight loss [5] Thyroid panel: to rule out thyroid disorders that can contribute to weight changes or mimic weight-related symptoms [6] Complete blood count and electrolytes: to check for underlying health issues or imbalances that could complicate early treatment [7] Important: Because Peak Wellness relies primarily on intake-based evaluation, patients with known medical conditions or incomplete health histories may want to discuss whether additional testing would be beneficial before starting treatment
Am J Physiol Regul Integr Comp Physiol 292, R7785, doi: 10.1152/ajpregu.00832.2005 (2007)
If your primary care physician diagnosed you with prediabetes two years ago, bring that record
Still, clinical trials show it can help lower body weight in people who have excess weight or do not have diabetes
Also referred to as post-treatment Lyme disease syndrome (PTLDS), it is characterized by symptoms that last for months or years
Each marking represents 5 units of U-500 insulin
